Barclays »

Sutro Biopharma shares owned by Barclays

Quarter-by-quarter ownership of Sutro Biopharma (STRO) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Sutro Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Sutro Biopharma held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sutro Biopharma by Barclays

Quarter filed Position value Share count Share price at filing
2026-03-31 $3.5k 139 24.91

More positions owned by Barclays

Ishares Tr Opt Put Option (EEM)
Microsoft Corporation (MSFT)
STATE STR SPDR S&ampP 500 ETF T Opt Call Option (SPY)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Opt Call Option (QQQ)
Ishares Tr Fund (IWM)
Apple (AAPL)
Amazon (AMZN)
Alphabet Inc Class A cs (GOOGL)
Facebook Inc cl a (META)
Broadcom (AVGO)
Tesla Motors (TSLA)
Ishares Tr Opt Put Option (HYG)
JPMORGAN CHASE &amp Opt Call Option (JPM)
Alphabet Inc Class C cs (GOOG)

View all positions for Barclays

Top funds holding Sutro Biopharma

BVF
Affinity Asset Advisors
Samsara BioCapital
Kynam Capital Management
OrbiMed Advisors
Vanguard Capital Management
RA Capital Management
Perceptive Advisors
Eventide Asset Management
Point72 Asset Management
ADAR1 Capital Management
Velan Capital Investment Management
Balyasny Asset Management
Woodline Partners
UBS Group

View all funds holding Sutro Biopharma